PTH and osteoporosis: Systemic drugs offer the advantage of providing therapy without surgical intervention, but while many systemic drugs acting on a range of targets are clinically approved for stimulating bone formation in osteoporosis (e.g., parathyroid hormone [PTH]), there are little data available to suggest these agents improve fracture healing in humans 4.